## 

## 





















## 





## 

||||31/01/2023|31/01/2022|
|---|---|---|---|---|
|||Notes|||
|Current assets|||||
|Debtors||10|1,669|600|
|Cash at bank|and in hand||111,188|103,155|
||||112857|103755|
|Creditors|||||
|Amounts<br>falling due within one year|||||
|Net Current|Assets||107,047|95,010|
|Total assets|less current liabilities||107,047|95,010|
|Funds|||||
|Unrestricted|funds|12|107,047|95,010|
|Total funds carried forward|||107,047|95010|















## 

## 

|Grants||||
|---|---|---|---|
|NHS England||2,200||
|Camurus|Ltd|20,200|6,000|
|Ethypharm|UK Ltd|1,200|650|
|Indivior|||200|
|||23,600|6,850|



## 

## 

|Membership||57,912|64,146|
|---|---|---|---|
|Conference|&training|6,500|6,300|
|Other income||350||
|||64,762|70,446|



## 

## 

|||||
|---|---|---|---|
|EXPENDITURE|ON CHARITABLE ACTIVITIES|2023|2022|
|External advisory|&supervision<br>work|56,882|45,662|
|Website, newsletter<br>& publicity<br>Conference<br>and training<br>activities||11,176|7,807<br>360|
|Travel &general administration<br>costs<br>Accountancy<br>&professional fees<br>Bad Debt||2,976<br>5,292|2,250<br>2,310<br>685|
|Other costs|||142|
|||76,325|59,216|





## 


## 

## 


## 









## 

## 



##